Time=Lives and Value-based Payment Models: Are They Working?

-

This session will open with a Time=Lives Talk by Sandra Abrevaya and Brian Wallach, Co-Founders of I AM ALS, followed by a panel discussion on Value-based Payment Models.

Value-based payment has long been viewed as a key approach to facilitating access while ensuring accountability for costs and quality. But when it comes to transformative technologies, such as gene therapies that carry price tags much higher than conventional therapies, are value-based payment models still the right approach? In this session, experts will discuss successes and challenges of implementing value-based payment. They will further explore how models are evolving to accommodate gene therapies. 

    Guest

    Image

    Sandra Abrevaya

    Co-Founder and CEO, Synapticure; Co-Founder, I AM ALS
    Image

    Brian Wallach

    Co-Founder and Board Chair, Synapticure; Co-Founder, I AM ALS

    Moderator

    Image

    Aneesh Chopra

    President, CareJourney

    Speakers

    Image

    Lee Fleisher

    Chief Medical Officer and Director, Center for Clinical Standards and Quality, Centers for Medicare & Medicaid Services
    Image

    Maia Z. Laing

    Patient Advocate, Zakara Inc.
    Image

    Hoangmai Pham

    Founder and President, Institute for Exceptional Care
    Image

    Jack Rollins

    Director of Federal Policy, National Association of Medicaid Directors